Despite being approved by the Food and Drug Administration for over 30 years, calcitonin salmon has seen a dramatic increase in acquisition cost over the last few years. Being commonly used for the treatment of hypercalcemia of malignancy, health systems must implement stewardship strategies in order to curtail usage. This review is intended to provide a background on calcitonin usage for hypercalcemia of malignancy and associated strategies to ensure appropriateness of utilization within health systems.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0897190018770052 | DOI Listing |
Publication Analysis
Top Keywords
stewardship strategies
8
hypercalcemia malignancy
8
health systems
8
calcitonin stewardship
4
strategies despite
4
despite approved
4
approved food
4
food drug
4
drug administration
4
administration years
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!